Financhill
Buy
52

TRVI Quote, Financials, Valuation and Earnings

Last price:
$11.46
Seasonality move :
60.39%
Day range:
$11.01 - $11.81
52-week range:
$3.77 - $14.39
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
7.74x
Volume:
1.6M
Avg. volume:
1.4M
1-year change:
169.01%
Market cap:
$1.5B
Revenue:
--
EPS (TTM):
-$0.37

Earnings Data

Next earnings date for TRVI
Mar 17
2026
Most recent earnings per share
-$0.08
Beat by $0.02
(Nov 13/2025)
Consensus Estimate
-$0.10
(Nov 13/2025)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

TRVI Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
03/31/2026 Q1 -- -- -- -$0.11 --
03/17/2026 Q4 -- -- -- -$0.10 --
11/13/2025 Q3 -- -- -$0.08 -$0.10 $0.02
08/07/2025 Q2 -- -- -$0.09 -$0.10 $0.01
05/08/2025 Q1 -- -- -$0.09 -$0.12 $0.03
03/18/2025 Q4 -- -- -$0.11 -$0.12 $0.01
11/06/2024 Q3 -- -- -$0.13 -$0.11 -$0.02
08/08/2024 Q2 -- -- -$0.12 -$0.11 -$0.01
05/07/2024 Q1 -- -- -$0.11 -$0.09 -$0.02
03/20/2024 Q4 -- -- -$0.08 -$0.09 $0.01
11/09/2023 Q3 -- -- -$0.08 -- --
08/10/2023 Q2 -- -- -$0.07 -- --
05/11/2023 Q1 -- -- -$0.06 -- --
03/16/2023 Q4 -- -- -$0.06 -- --
11/10/2022 Q3 -- -- -$0.12 -- --
08/11/2022 Q2 -- -- -$0.14 -- --
05/12/2022 Q1 -- -- -$0.24 -- --
03/17/2022 Q4 -- -- -$0.30 -- --
11/10/2021 Q3 -- -- -$0.34 -- --
08/12/2021 Q2 -- -- -$0.49 -- --
05/13/2021 Q1 -- -- -$0.43 -- --
03/25/2021 Q4 -- -- -$0.52 -- --
11/11/2020 Q3 -- -- -$0.41 -- --
08/12/2020 Q2 -- -- -$0.41 -- --
05/07/2020 Q1 -- -- -$0.48 -- --
03/16/2020 Q4 -- -- -$0.37 -- --
11/14/2019 Q3 -- -- -$0.41 -- --
08/12/2019 Q2 -- -- -$0.63 -- --
06/13/2019 Q1 -- -- -$0.35 -- --
12/31/2018 Q4 -- -- -$0.41 -- --
09/30/2018 Q3 -- -- -$0.40 -- --
06/30/2018 Q2 -- -- -$0.34 -- --
03/31/2018 Q1 -- -- -$0.29 -- --
12/31/2017 Q4 -- -- -$0.22 -- --

Trevi Therapeutics, Inc. Earnings Questions

  • How Much did Trevi Therapeutics, Inc. Generate in Revenue Last Quarter?

    Trevi Therapeutics, Inc. reported -- worth of top line sales in its most recent quarter.

  • Did Trevi Therapeutics, Inc. Beat Earnings Last Quarter?

    Trevi Therapeutics, Inc. announced earnings per share of -$0.08 which represents a beat of analyst forecast a -$0.10 per share.

  • Is Trevi Therapeutics, Inc. Profitable?

    Trevi Therapeutics, Inc. reported -$38K that represents -$0.00 per share over the last quarter.

  • What is the Analyst Consensus for Trevi Therapeutics, Inc. EPS Next Year?

    Trevi Therapeutics, Inc.'s earnings are forecast to decrease from -$0.47 per share to -$0.45 per share next year representing a decrease of -0.04%.

  • When is Trevi Therapeutics, Inc.'s Earnings Date?

    Trevi Therapeutics, Inc.'s next earnings date is March 17, 2026.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Will UnitedHealth Stock Recover?
Will UnitedHealth Stock Recover?

Shares of embattled health insurance giant UnitedHealth (NYSE:UNH) plummeted by…

Is Lumentum The Best Laser Stock to Buy?
Is Lumentum The Best Laser Stock to Buy?

Though certainly less well-known than the huge tech businesses that…

Is Planet Fitness Stock Undervalued?
Is Planet Fitness Stock Undervalued?

Planet Fitness (NYSE:PLNT) has had a difficult 12 months, retreating…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
61
Is AAPL Stock a Buy?

Market Cap: $4.1T
P/E Ratio: 37x

Buy
53
Is GOOG Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 30x

Alerts

Sell
40
BILL alert for Feb 7

Bill Holdings, Inc. [BILL] is up 37.11% over the past day.

Buy
75
PRLB alert for Feb 7

Proto Labs, Inc. [PRLB] is up 28.33% over the past day.

Sell
30
MSTR alert for Feb 7

Strategy, Inc. [MSTR] is up 26.08% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock